Cargando…

Correlations of EZH2 and SMYD3 gene polymorphisms with breast cancer susceptibility and prognosis

The aim of the present study was to investigate the correlation of enhancer of Zeste homolog 2 (EZH2) and SET and MYND domain containing 3 (SMYD3) gene polymorphisms with breast cancer susceptibility and prognosis. A total of 712 patients with breast cancer and 783 healthy individuals were selected....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Shao-Jun, Liu, Yan-Mei, Zhang, Yue-Lang, Chen, Ming-Wei, Cao, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794497/ https://www.ncbi.nlm.nih.gov/pubmed/29089464 http://dx.doi.org/10.1042/BSR20170656

Ejemplares similares

EZH2 and SMYD3 expression in papillary thyroid cancer
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

SET and MYND Domain-Containing Protein 3 (SMYD3) Polymorphism as a Risk Factor for Susceptibility and Poor Prognosis in Ovarian Cancer
por: Liu, Ting-Ting, et al.
Publicado: (2016)

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma
por: Binh, Mai Thanh, et al.
Publicado: (2020)

SMYD2 aggravates gastrointestinal stromal tumor via upregulation of EZH2 and downregulation of TET1
por: Ji, Yong, et al.
Publicado: (2022)

Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features
por: Yu, Yung-Luen, et al.
Publicado: (2014)

The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma
por: Wu, Shi-yi, et al.
Publicado: (2022)

Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma
por: Yu, Yung-Luen, et al.
Publicado: (2013)

Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma
por: Zuo, Shan-Ru, et al.
Publicado: (2018)

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer
por: Pietersen, Alexandra M, et al.
Publicado: (2008)

Polymorphism in the EREG gene confers susceptibility to tuberculosis
por: Cao, Wen, et al.
Publicado: (2019)

SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
por: Fenizia, Claudio, et al.
Publicado: (2019)

The roles of SMYD4 in epigenetic regulation of cardiac development in zebrafish
por: Xiao, Deyong, et al.
Publicado: (2018)

EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia
por: Chu, Ming‐qiang, et al.
Publicado: (2019)

Lethal-7-related polymorphisms are associated with susceptibility to and prognosis of gastric cancer
por: Jia, Zhi-Fang, et al.
Publicado: (2019)

Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology
por: Liu, Liang-Chih, et al.
Publicado: (2022)

Evolutionary History of the Smyd Gene Family in Metazoans: A Framework to Identify the Orthologs of Human Smyd Genes in Drosophila and Other Animal Species
por: Calpena, Eduardo, et al.
Publicado: (2015)

Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray
por: Stewart, M. David, et al.
Publicado: (2016)

Expression and Functional Characterization of Smyd1a in Myofibril Organization of Skeletal Muscles
por: Gao, Jie, et al.
Publicado: (2014)

SMYD3 promotes colon adenocarcinoma (COAD) progression by mediating cell proliferation and apoptosis
por: Yue, Fu-Ren, et al.
Publicado: (2020)

Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors
por: Liu, Donghui, et al.
Publicado: (2021)

Smyd1b is required for skeletal and cardiac muscle function in zebrafish
por: Li, Huiqing, et al.
Publicado: (2013)

SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis
por: Ye, Xiangli, et al.
Publicado: (2016)

Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model
por: Williams, Jamal B., et al.
Publicado: (2023)

Histone methyltransferase SMYD2: ubiquitous regulator of disease
por: Yi, Xin, et al.
Publicado: (2019)

SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer
por: Liu, Donghui, et al.
Publicado: (2023)

Histone methyltransferase Smyd3 is a new regulator for vascular senescence
por: Yang, Di, et al.
Publicado: (2020)

Expression of EZH2 in uveal melanomas patients and associations with prognosis
por: Cheng, Ying, et al.
Publicado: (2017)

Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
por: Li, Linda Xiaoyan, et al.
Publicado: (2018)

Anticancer Impact of Nitric Oxide (NO) and NO Combination with SMYD-3 Inhibitor on Breast Carcinomas
por: Gordon, Jenna L., et al.
Publicado: (2021)

Unique SMYD5 Structure Revealed by AlphaFold Correlates with Its Functional Divergence
por: Zhang, Yingxue, et al.
Publicado: (2022)

SMYD2 promotes cervical cancer growth by stimulating cell proliferation
por: Sun, Jun-Jie, et al.
Publicado: (2019)

Role of Circ-ITCH Gene Polymorphisms and Its Expression in Breast Cancer Susceptibility and Prognosis
por: Saadawy, Sara F., et al.
Publicado: (2023)

Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia
por: Chen, Ying, et al.
Publicado: (2019)

STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression
por: Ma, Wei, et al.
Publicado: (2018)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

Correlation between heparanase gene polymorphism and susceptibility to endometrial cancer
por: Cao, Hanyu, et al.
Publicado: (2020)

Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis
por: Zhang, Ming, et al.
Publicado: (2019)

SMYD2 promoter DNA methylation is associated with abdominal aortic aneurysm (AAA) and SMYD2 expression in vascular smooth muscle cells
por: Toghill, Bradley J., et al.
Publicado: (2018)

The impact of Angiopoietin-2 genetic polymorphisms on susceptibility for malignant breast neoplasms
por: Hu, Gui-Nv, et al.
Publicado: (2022)

SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
por: Li, Jing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5k252i343kpnl2oedvq05aogvn